Dr. Brenda Herschbach Jarrell Named 2016 “Attorney of the Year - Patent Strategy & Management - Massachusetts” by LMG Life Sciences

Press Release

 | September 15, 2016

Boston, MA, September 15, 2016 – Choate, Hall & Stewart LLP announced today that Dr. Brenda Herschbach Jarrell, co-chair of the firm’s Life Sciences and Intellectual Property (IP) Groups, has been named 2016 “Attorney of the Year - Patent Strategy & Management - Massachusetts” by LMG Life Sciences.  The firm was also named a finalist in the 2016 “Patent Strategy and Management Firm of the Year” category.  The annual LMG Life Sciences awards recognize the leading attorneys, law firms, and in-house counsel teams that have played a significant role in the life sciences industry over the last 12 months.  An awards ceremony was held on September 14, 2016 in New York City.

With scientific training that spans the disciplines of theoretical quantum physics to synthetic organic chemistry to molecular biology, Dr. Jarrell is one of the most sought after and highly regarded life sciences and IP attorneys in the country.  Revered by companies that are developing cutting edge innovations in areas such as small molecule therapeutics, biologics, vaccines, diagnostic technologies, and nanomedicines, Dr. Jarrell’s prestigious clients include large pharma companies, leading research organizations, innovative industry leaders, and large investment firms.

As co-chair of Choate’s Life Sciences and IP Groups, Dr. Jarrell leads an award-winning team comprised of nearly 40 IP attorneys, patent agents, and staff scientists – many with PhDs or other advanced degrees – who have significant industry experience in a wide range of biotech, pharmaceutical, and specialty chemical industries.  The team, which was named LMG Life Sciences’ “Patent Strategy and Management Firm of the Year” last year, represents leading life sciences companies and institutions in all aspects of their business including IP protection, strategies, IPRs, collaborations and licenses, technology transfer, financings, M&A transactions, and general advice and counsel.

The Legal Media Group publishes the LMG Life Sciences guide annually in association with Euromoney Institutional Investor.  The guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and a review of public information.


Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.